Novel carbazole-thiadiazole derivatives as α-amylase and α-glucosidase inhibitors: Design, biological evaluation, and computational insights
Bioorganic Chemistry · 2025
DOI: 10.1016/j.bioorg.2025.108243 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioorganic Chemistry, 2025. Verfasst von İrfan Çapan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Basic Sciences, Faculty of Pharmacy, Gazi University, 06330 Ankara, Turkey; Sente Kimya Research and Development Inc., 0…. Hauptthemen laut MEDLINE: Thiadiazoles, Carbazoles, Glycoside Hydrolase Inhibitors, alpha-Glucosidases. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: Gazi University.
Abstract (Originalsprache)
Diabetes mellitus remains a global health challenge, demanding innovative therapeutic solutions. Herein, we present the design, synthesis, and pharmacological evaluation of a novel series of carbazole-thiadiazole hybrids targeting key enzymes in carbohydrate metabolism. Among the synthesized compounds, 5l emerged as the most potent inhibitor of α-amylase, with an IC50 value of 0.68 µM-far surpassing the efficacy of the standard drug acarbose (IC50: 5.19 µM). Similarly, 5r exhibited exceptional dual activity against both α-amylase and α-glucosidase, with IC50 values of 1.63 µM and 0.14 µM, respectively, highlighting its dual inhibitory potential. Biological assays demonstrated the compounds' low cytotoxicity on hepatic stellate (LX-2) cells, affirming their safety for therapeutic use. Molecular docking studies provided mechanistic insights into their binding interactions, revealing strong hydrogen bonding and hydrophobic interactions with key active site residues. Density functional theory (DFT) and electrostatic potential (ESP) analyses further elucidated their electronic properties, offering a deeper understanding of their structure-activity relationships. Pharmacokinetic profiling via the BOILED-Egg model confirmed these derivatives' excellent oral bioavailability and drug-likeness. Collectively, these findings establish carbazole-thiadiazole hybrids as promising candidates for next-generation antidiabetic therapies, warranting further investigation in preclinical and clinical settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Basic Sciences, Faculty of Pharmacy, Gazi University, 06330 Ankara, Turkey; Sente Kimya Research and Development Inc., 06200 Ankara, Turkey. Electronic address: irfancapan@gazi.edu.tr.
- Pharmaceutical Chemistry and Technology Division, Faculty of Pharmacy, An-Najah National University, Nablus, Palestine.
- Department of Pharmacy, Faculty of Pharmacy, Cyprus International University, Northern Cyprus, Mersin 10, 99258 Nicosia, Turkey.
Förderung
- Gazi University
Zitieren
APA
Çapan, İ., Hawash, M., Qaoud, M. T., & Jaradat, N. (2025). Novel carbazole-thiadiazole derivatives as α-amylase and α-glucosidase inhibitors: Design, biological evaluation, and computational insights. Bioorganic Chemistry. https://doi.org/10.1016/j.bioorg.2025.108243
Vancouver
Çapan İ, Hawash M, Qaoud MT, Jaradat N. Novel carbazole-thiadiazole derivatives as α-amylase and α-glucosidase inhibitors: Design, biological evaluation, and computational insights. Bioorganic Chemistry. 2025. doi:10.1016/j.bioorg.2025.108243
BibTeX
@article{apan2025,
author = {Çapan, İrfan and Hawash, Mohammed and Qaoud, Mohammed T and Jaradat, Nidal},
title = {Novel carbazole-thiadiazole derivatives as α-amylase and α-glucosidase inhibitors: Design, biological evaluation, and computational insights},
journal = {Bioorganic Chemistry},
year = {2025},
doi = {10.1016/j.bioorg.2025.108243}
}
EUVIMED